Price Alert

Oncternal Therapeutics In... (ONCT)

NASDAQ: ONCT · Real-Time Price · USD

0.53

-0.16 (-23.63%)

At close: Dec 02, 2024, 10:00 PM

Oncternal Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	13.08M	6.38M	6.4M	6.7M	14.93M	15.83M	11.24M	37.14M	70.63M	78.9M	82.16M	90.77M	97.38M	103.66M	111.21M
Short-Term Investments	1.5M	15.05M	20.63M	27.56M	25.38M	29.67M	43.07M	26.58M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	412K	412K	412K	412K	332K	315K	1.27M	1.26M	389K	391K	657K	657K	658K	769K
Receivables	344K	563K	717K	632K	n/a	n/a	n/a	178K	n/a	38K	n/a	585K	n/a	n/a	n/a
Inventory	n/a	n/a	n/a	n/a	-186K	-262K	n/a	103K	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	507K	348K	335K	606K	n/a	n/a	n/a	n/a	4.16M	n/a	n/a	359K	2.14M	3.94M	1.87M
Total Current Assets	15.45M	23.26M	28.5M	36.06M	42.49M	50.08M	57.92M	67.29M	74.79M	80.98M	85.07M	92.85M	99.52M	107.6M	113.08M
Property-Plant & Equipment	154K	190K	225K	258K	291K	366K	50K	87K	122K	157K	31K	75K	119K	162K	204K
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	154K	602K	637K	670K	703K	698K	365K	1.36M	1.38M	546K	422K	732K	776K	820K	973K
Total Assets	15.6M	23.86M	29.14M	36.73M	43.2M	50.77M	58.28M	68.65M	76.17M	81.53M	85.49M	93.58M	100.3M	108.42M	114.06M
Account Payables	1.2M	1.9M	1.46M	1.15M	2.13M	2.22M	1.96M	2.92M	2.46M	2.52M	2.4M	1.96M	2.75M	1.01M	1.89M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	118K	211K	n/a	-75K	158K	2.24M	885K
Short-Term Debt	n/a	n/a	n/a	n/a	151K	145K	n/a	n/a	122K	144K	31K	n/a	119K	162K	n/a
Other Current Liabilities	5.06M	n/a	n/a	n/a	1.48M	1.09M	1.11M	n/a	2.82M	2.9M	1.68M	n/a	1.33M	1.34M	2.07M
Total Current Liabilities	6.45M	8.05M	6.12M	5.2M	5.15M	4.83M	5.49M	7.68M	7.63M	7.51M	5.29M	5.46M	5.82M	5.9M	5.72M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	1.33M	856K	537K	306K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	n/a	50K	99K	1.48M	1.05M	758K	306K	3M	2.7M	13K	2.43M	1.96M	n/a	n/a	31K
Total Liabilities	6.45M	8.11M	6.21M	6.68M	6.2M	5.59M	5.79M	7.68M	7.63M	7.53M	5.29M	5.46M	5.82M	5.9M	5.75M
Total Debt	191K	235K	278K	318K	342K	366K	50K	87K	122K	157K	31K	75K	119K	162K	204K
Common Stock	3K	3K	3K	3K	59K	59K	59K	57K	56K	52K	49K	49K	49K	49K	49K
Retained Earnings	-223.19M	-214.73M	-206.17M	-197.78M	-188.62M	-178.75M	-169.79M	-158.3M	-146.9M	-135.78M	-124.03M	-114.13M	-106.06M	-96.43M	-88.75M
Comprehensive Income	1K	-3K	-8K	3K	0.00	-6K	11K	9K	n/a	0.00	n/a	n/a	-0.00	0.00	n/a
Shareholders Equity	9.15M	15.75M	22.93M	30.05M	-188.62M	-178.75M	52.49M	-158.3M	68.54M	74M	80.19M	-114.13M	94.48M	102.52M	108.3M
Total Investments	1.5M	15.05M	20.63M	27.56M	25.38M	29.67M	43.07M	26.58M	n/a	n/a	n/a	n/a	n/a	n/a	n/a